Calprotectin is a useful tool in distinguishing coexisting irritable bowel-like symptoms from that of occult inflammation among inflammatory bowel disease patients in remission

Gastroenterology Research and Practice

Volumn 2013, Issue , 2013, Pages

  Jelsness Jørgensen, Lars Petter ^a,b   Bernklev, Tomm ^c   Moum, Bjørn ^d  

^a Ostfold Hospital Trust   (Norway)

^b ØSTFOLD UNIVERSITY COLLEGE   (Norway)

^c TELEMARK HOSPITAL   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN;

ADULT; AGED; ARTICLE; COLON CROHN DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; ENDOSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; REMISSION; SCORING SYSTEM; SIMPLE CLINICAL COLITIS ACTIVITY INDEX; ULCERATIVE COLITIS;

EID: 84874634689     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2013/620707     Document Type: Article

References (15)

1. Loftus E. V., Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004 126 6 1504 1517 2-s2.0-2442563304 10.1053/j.gastro.2004.01.063 (Pubitemid 38649869)
2. Schoepfer A. M., Trummler M., Seeholzer P., Seibold-Schmid B., Seibold F., Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflammatory Bowel Diseases 2008 14 1 32 39 2-s2.0-38849194737 10.1002/ibd.20275 (Pubitemid 351196866)
3. Keohane J., O'Mahony C., O'Mahony L., O'Mahony S., Quigley E. M., Shanahan F., Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation. American Journal of Gastroenterology 2010 105 8 1789 1794 2-s2.0-77955419649 10.1038/ajg.2010.156
4. Simrén M., Axelsson J., Gillberg R., Abrahamsson H., Svedlund J., Björnsson E. S., Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. American Journal of Gastroenterology 2002 97 2 389 396 2-s2.0-0036177386 10.1016/S0002-9270(01)04037-0 (Pubitemid 34160766)
5. Roseth A. G., Fagerhol M. K., Aadland E., Schjonsby H., Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scandinavian Journal of Gastroenterology 1992 27 9 793 798 2-s2.0-0026744132
6. Walmsley R. S., Ayres R. C. S., Pounder R. E., Allan R. N., A simple clinical colitis activity index. Gut 1998 43 1 29 32 2-s2.0-0031812412 (Pubitemid 28335486)
7. Harvey R. F., Bradshaw J. M., A simple index of Crohn's-disease activity. The Lancet 1980 315 8167 514 515 2-s2.0-0019319257
8. Thompson W. G., Creed F. H., Drossman D. A., Heaton K. W., Mazzacca G., Functional bowel disease and functional abdominal pain. Gastroenterology International 1992 5 2 75 91 2-s2.0-0026662514
9. Fagerhol M. K., Calprotectin, a faecal marker of organic gastrointestinal abnormality. The Lancet 2000 356 9244 1783 1784 2-s2.0-0034715965
10. af Björkesten C. G., Nieminen U., Turunen U., Arkkila P., Sipponen T., Färkillä M., Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease. Scandinavian Journal of Gastroenterology 2012 47 528 537
11. Minderhoud I. M., Oldenburg B., Wismeijer J. A., Van Berge Henegouwen G. P., Smout A. J. P. M., IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Digestive Diseases and Sciences 2004 49 3 469 474 2-s2.0-1842608600 10.1023/B:DDAS.0000020506.84248.f9 (Pubitemid 38453568)
12. Vermeire S., Van Assche G., Rutgeerts P., Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 2006 55 3 426 431 2-s2.0-33144460914 10.1136/gut.2005.069476 (Pubitemid 43268284)
13. Tibble J., Teahon K., Thjodleifsson B., Roseth A., Sigthorsson G., Bridger S., Foster R., Sherwood R., Fagerhol M., Bjarnason I., A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000 47 4 506 513 2-s2.0-0033795259 10.1136/gut.47.4.506
14. D'Incà R., Dal Pont E., Di Leo V., Benazzato L., Martinato M., Lamboglia F., Oliva L., Carlo Sturniolo G., Can calprotectin predict relapse risk in inflammatory bowel disease? American Journal of Gastroenterology 2008 103 8 2007 2014 2-s2.0-49349114912 10.1111/j.1572-0241.2008.01870.x
15. Sipponen T., Savilahti E., Kolho K. L., Nuutinen H., Turunen U., Färkkilä M., Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings. Inflammatory Bowel Diseases 2008 14 1 40 46 2-s2.0-38849204268 10.1002/ibd.20312 (Pubitemid 351196867)